Success Metrics

Clinical Success Rate
100.0%

Based on 12 completed trials

Completion Rate
100%(12/12)
Active Trials
1(8%)
Results Posted
83%(10 trials)

Phase Distribution

Ph phase_2
4
31%
Ph phase_1
1
8%
Ph phase_3
7
54%

Phase Distribution

1

Early Stage

4

Mid Stage

7

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
4(33.3%)
Phase 3Large-scale testing
7(58.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

12 of 12 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(12)

Detailed Status

Completed12
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (8.3%)
Phase 24 (33.3%)
Phase 37 (58.3%)

Trials by Status

completed1292%
active_not_recruiting18%

Recent Activity

1 active trials
Showing 5 of 13
completedphase_2

Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)

NCT03596905
active_not_recruitingphase_1

GCC Agonist Signal in the Small Intestine

NCT05107219
completedphase_3

Efficacy and Safety of Plecanatide Comparing With Placebo in the Treatment of Functional Constipation

NCT05151328
completedphase_3

Long Term Safety Study of Plecanatide

NCT02706483
completedphase_3

12-Week Study of Plecanatide for CIC (The CIC3 Study)

NCT01982240
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT03596905Phase 2

Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)

Completed
NCT05107219Phase 1

GCC Agonist Signal in the Small Intestine

Active Not Recruiting
NCT05151328Phase 3

Efficacy and Safety of Plecanatide Comparing With Placebo in the Treatment of Functional Constipation

Completed
NCT02706483Phase 3

Long Term Safety Study of Plecanatide

Completed
NCT01982240Phase 3

12-Week Study of Plecanatide for CIC (The CIC3 Study)

Completed
NCT03551873

A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®

Completed
NCT03120520Phase 2

An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation

Completed
NCT01919697Phase 3

Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)

Completed
NCT02493452Phase 3

Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)

Completed
NCT02387359Phase 3

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Completed
NCT01722318Phase 2

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)

Completed
NCT02122471Phase 3

12-Week Study of Plecanatide for CIC (The National CIC3 Study)

Completed
NCT01429987Phase 2

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13